Showing results (1-10 of 561) with videos related to

Sort By:
Pageof 57
Current Opinion in Cardiology|August 30, 2019
Modulation of cholesterol efflux capacity in patients with myocardial infarctionJohanne Silvain, Mathieu Kerneis, Maryse Guerin, et al.
Progress in Cardiovascular Diseases|January 18, 2018
Anticoagulation in Acute Coronary Syndrome-State of the ArtMichel Zeitouni, Mathieu Kerneis, Tarek Nafee, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Dual antiplatelet therapy: optimal timing, management, and durationPierre Sabouret, Sophie K Rushton-Smith, Mathieu Kerneis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 12, 2020
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitationsMichel Zeitouni, Pierre Sabouret, Mathieu Kerneis, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 5, 2019
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?Michel Zeitouni, Mathieu Kerneis, Benoit Lattuca, et al.
Drugs & Aging|April 7, 2019
Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered ApproachBenoit Lattuca, Mathieu Kerneis, Michel Zeitouni, et al.
Archives of Cardiovascular Diseases|January 15, 2019
Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary interventionLee S Nguyen, Vincent Spagnoli, Mathieu Kerneis, et al.
Archives of Cardiovascular Diseases|June 27, 2015
Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarctionMathieu Kerneis, Johanne Silvain, Jérémie Abtan, et al.
The American Journal of Cardiology|March 3, 2015
Updates and current recommendations for the management of patients with non-ST-elevation acute coronary syndromes: what it means for clinical practiceGuillaume Cayla, Johanne Silvain, Jean-Philippe Collet, et al.
European Heart Journal. Acute Cardiovascular Care|May 6, 2025
Role of sub-clinical inflammation and defective cholesterol efflux in myocardial infarction patients without standard modifiable risk factorsVincent Roule, Farzin Beygui, Maryse Guerin, et al.
Pageof 57